OKLAHOMA CITY (AP) — Oklahoma health officials announced Monday plans to resume distribution of the one-shot Johnson & Johnson vaccine following rare cases of blood clots potentially linked to the vaccine.
The decision comes following a recommendation from both the U.S. Centers for Disease Control and Prevention and the Food and Drug Administration, Deputy Health Commissioner Keith Reed said.
"They have identified 15 cases of the occurrence among nearly 8 million total doses administered," Reed said in a statement. "The vaccine has been authorized to resume administration with the addition of a warning label explaining the potential for rare side effects."
Both federal agencies earlier this month had recommended a pause in the distribution of the one-dose vaccine after reports of rare blood clotting, and Oklahoma paused distribution on April 13.
State health officials say the one-dose vaccine is ideal for rural areas and for people who may have problems scheduling more than one appointment.
Meanwhile, Oklahoma reported 262 confirmed new cases of coronavirus on Monday and 23 additional deaths since Friday. That brings the total number of confirmed cases in Oklahoma to 447,278 and the state's death count to 8,229, based on death certificates provided to the CDC.